PERSPECTA

News from every angle

← Back to headlines

Evogene Addresses Dissident Shareholder Concerns

Biotech company Evogene outlines its transformation strategy and commercial progress in response to activist shareholder pressure.

31 Aug, 12:23 — 31 Aug, 12:23
PostShare

Sources

Showing 1 of 1 sources
morningstar3d ago

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - Morningstar

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward  Morningstar

Read full article →

Related Stories

Revolut Secures Conditional U.S. National Bank Charter

25m ago

Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs

33m ago

Canada’s Trade Surplus Narrows in July Amid Falling Exports

39m ago

Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter

51m ago